TY - JOUR T1 - The impact of asymptomatic COVID-19 infections on future pandemic waves JF - medRxiv DO - 10.1101/2020.06.22.20137489 SP - 2020.06.22.20137489 AU - Spencer J Fox AU - Remy Pasco AU - Mauricio Tec AU - Zhanwei Du AU - Michael Lachmann AU - James Scott AU - Lauren Ancel Meyers Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/23/2020.06.22.20137489.abstract N2 - The prevalence of asymptomatic COVID-19 infections is largely unknown and may determine the course of future pandemic waves and the effectiveness of interventions. Using an epidemiological model fit to COVID-19 hospitalization counts from New York City, New York and Austin, Texas, we found that the undocumented attack rate in the first pandemic wave depends on the proportion of asymptomatic infections but not on the infectiousness of such individuals. Based on a recent report that 22.7% of New Yorkers are seropositive for SARS-CoV-2, we estimate that 56% (95% CI: 53-59%) of COVID-19 infections are asymptomatic. Given uncertainty in the case hospitalization rate, however, the asymptomatic proportion could be as low as 20% or as high as 80%. We find that at most 1.26% of the Austin population was infected by April 27, 2020 and conclude that immunity from undetected infections is unlikely to slow future pandemic spread in most US cities in the summer of 2020.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFinancial support was provided by US National Institutes of Health (grant no U01 GM087719) the National Natural Science Foundation of China (grant no 61773091) and Titos Handmade VodkaAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code available on request. Currently working on a clean github repository to store it. ER -